AP
ELAN icon

Arlington Partners’s Elanco Animal Health ELAN Stock Holding History

Arlington Partners’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-412
Closed -$12K – 342
2021
Q1 		$12K Hold
412
– – ﹤0.01% 328
2020
Q4 		$13K Buy
+412
New +$12.6K 0.01% 173

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Arlington Partners's ELAN Position: Q2 2021 in Review

Arlington Partners sold out of Elanco Animal Health (ELAN) in Q2 2021, closing a stake of 412 shares — an estimated $12K sold.

Arlington Partners first reported a position in ELAN in Q4 2020 and held it in 2 quarters. The position peaked at $13K in Q4 2020. 479 funds tracked by Wall St. Rank hold ELAN as of Q2 2021.

  • Arlington Partners reported no remaining Elanco Animal Health position as of Q2 2021 after selling out during the quarter.
  • Arlington Partners sold 412 Elanco Animal Health shares in Q2 2021, an estimated $12K.
  • Arlington Partners first reported a position in Elanco Animal Health in Q4 2020 and held it in 2 quarters.
  • Arlington Partners's Elanco Animal Health position peaked at $13K in Q4 2020.
  • 479 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2021.

Based on Arlington Partners's 13F filing for Q2 2021, filed 7 Jul 2021.